Amisulprid-Mepha 200, Tabletten

7680595140027 CH-59514 Tabletten
Amisulprid-Mepha 200, Tabletten
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
90
Selling units
90
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/02/2026
Patient information leaflet
Français
25/02/2026
Patient information leaflet
Italien
25/02/2026
Summary of Product Characteristics
Allemand
24/02/2026
Summary of Product Characteristics
Français
24/02/2026
Summary of Product Characteristics
Italien
24/02/2026

Detailed composition

Substance Quantity Type Category
amisulpridum
200.0 MG Substance Wirkstoff (Principe actif)
maydis amylum
- Substance HNIDK
lactosum monohydricum
197.5 MG Substance HBESI
methylcellulosum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK

Reimbursement information

Public price
CHF 84.85
Specialties list
Yes
Generic
Yes
SL addition date: 01/09/2010

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
59514
Drug name
Amisulprid-Mepha, Tabletten
Galenic form
TAB
ATC Code
N05AL05
Authorization status
Z
Dispensing category
B
First authorization
05/07/2010
Authorization expiration date
31/12/9999
IT Number
01.05.0.
Domain
Human medicine
Field of application
Neuroleptikum

Package details

Description (FR)
AMISULPRID Mepha cpr 200 mg 90 pce
Description (DE)
AMISULPRID Mepha Tabl 200 mg 90 Stk
Market launch
05/07/2010
Narcotic (BTM)
No

Original drug

Solian, comprimés pelliculés sécables
GTIN: 7680605050018
CHF 63.10
View original

Other package sizes (1)

AMISULPRID Mepha cpr 200 mg 30 pce
30 TABL
GTIN: 7680595140010
View
Buy us a coffee Explore the data